Tilray Brands, Inc. (TLRY.TO)
| Previous Close | 3.8000 |
| Open | 3.8200 |
| Bid | 3.8900 x N/A |
| Ask | 3.9300 x N/A |
| Day's Range | 3.7400 - 3.9500 |
| 52 Week Range | 3.6000 - 17.4600 |
| Volume | |
| Avg. Volume | 1,765,888 |
| Market Cap | 2.304B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 7.15 |
| EPS (TTM) | 0.5500 |
| Earnings Date | Oct 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Motley Fool
2 Beaten-Down Stocks I Wouldn't Buy With Free Money
There is always an opportunity cost to consider -- like earning a worse return as a result of making a poor investment decision. A couple of stocks that look too risky to buy with even free money are Tilray Brands (NASDAQ: TLRY) and BlackBerry (NYSE: BB).
- GlobeNewswire
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland
Tilray’s Medical Cannabis Product Now Available and Reimbursed Under Ireland’s Medical Cannabis Access ProgramLEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that it has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under th
- Bloomberg
US Earnings to Watch: Levi, Constellation Brands, Tilray
(Bloomberg) -- The hawkish tone reiterated by Fed officials this week sent jitters into stocks and raised market volatility as investors confront dimming prospects over the strength of consumer demand for products ranging from used cars to personal technology going into the holiday season. With just two weeks before major US bank earnings kick off again, market watchers will get a sense of how the persistent unfavorable macroeconomic conditions play out in the earnings reports of home equipment
